E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/13/2006 in the Prospect News Biotech Daily.

Jefferies puts ICON at buy

Jefferies & Co., Inc. analyst David Windley rated ICON plc at buy. The analyst remains positive about the company's visibility into calendar year 2007. In addition, management is confident that current backlog can support 76% of consensus revenue expectations over the next 12 months, according to Windley. Shares of the Dublin, Ireland-based contract research organization were up 38 cents, or 0.99%, at $38.84. (Nasdaq: ICLR)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.